lopinavir has been researched along with AIDS Seroconversion in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (61.90) | 29.6817 |
2010's | 6 (28.57) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
Authors | Studies |
---|---|
Eleje, GU; Ikechebelu, JI; Nwagha, UI; Okafor, HU; Ugwu, AO; Ugwu, EO; Umeh, UA | 1 |
Domínguez-Castro, M; Figueroa-Damián, R; Galindo-Sevilla, N; Hernández-Pineda, J; Irles, C; Jung-Cook, HH; Katende-Kyenda, NL; Ramírez-Ramírez, A; Romo-Yañéz, J | 1 |
Abgrall, S; Antinori, A; Cavassini, M; Costagliola, D; Crane, HM; Gill, MJ; Gomez Sirvent, JL; Guest, JL; Ingle, SM; Manzardo, C; May, MT; Mercie, P; Mugavero, MJ; Phillips, A; Reekie, J; Reiss, P; Saag, MS; Samji, H; Stephan, C; Sterling, TR; Sterne, JA; Tate, J; Wasmuth, JC | 1 |
Boissonnault, M; Charest, L; Galanakis, C; Huchet, E; Longpré, D; Machouf, N; Murphy, D; Thomas, R; Trottier, B; Vézina, S | 1 |
Boutté, P; Monpoux, F; Pitelet, G; Richelme, C | 1 |
Baxter, L; Bryant, J; Hird, S | 1 |
Doroshyenko, O; Frank, D; Fuhr, U; Jetter, A; Lütjohann, D; Tomalik-Scharte, D | 1 |
Boven, K; Esposito, S; Feiterna-Sperling, C; Giaquinto, C; Kakuda, TN; Königs, C; Leemans, R; Mack, R; Peeters, I; Peeters, M; Rosso, R; Sinha, R; Viscoli, C | 1 |
Arminio Monforte, A; Bai, F; Bini, T; Carpani, G; Iannotti, N; Marchetti, G; Merlini, E; Savoldi, A; Sinigaglia, E; Tincati, C | 1 |
Anderson, AM; Chane, T; Chen, S; Easley, KA; Patel, M; Xue, W | 1 |
Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F | 1 |
Fulgaro, C; Legnani, G; Sabbatani, S | 1 |
Berger, F; Jaeger, H; Kurowski, M; Mauss, S; Rockstroh, JK; Schmutz, G; Scholten, S; Wolf, E | 1 |
Michaelis, HC; Rockstroh, JK; Sauerbruch, T; Spengler, U; Sudhop, T; Türler, A; Vogel, M; Voigt, E; Wolff, M | 1 |
Arici, C; Carosi, G; Ladisa, N; Maggiolo, F; Minoli, L; Orani, AM; Paraninfo, G; Patroni, A; Pierotti, P; Sighinolfi, L; Suter, F; Tinelli, C; Torti, C | 1 |
Brůcková, M; Konvalinka, J; Linka, M; Machala, L; Stanková, M; Václavíková, J; Vandasová, J | 1 |
Jäger, H; Theobald, T | 1 |
Bates, DE; Herman, RJ | 1 |
Ahlenstiel, G; Altfeld, M; Kaufmann, DE; Kupfer, B; Lichterfeld, M; Mui, SK; Rockstroh, JK; Spengler, U; Vogel, M; Voigt, E; Walker, B | 1 |
Beytout, J; Bocquier, B; Cormerais, L; Jacomet, C; Laurichesse, H; Lesens, O; Lyonne, L; Magimel, C; Trouillier, S; Zenut, M | 1 |
Olivier, D | 1 |
2 review(s) available for lopinavir and AIDS Seroconversion
Article | Year |
---|---|
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
Topics: Antiviral Agents; Coinfection; DNA, Viral; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnant Women; Ritonavir; Tenofovir; Zidovudine | 2023 |
Non-occupational postexposure prophylaxis for HIV: a systematic review.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Databases, Bibliographic; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lopinavir; Premedication; Pyrimidinones; Ritonavir; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Unsafe Sex; Zidovudine | 2009 |
3 trial(s) available for lopinavir and AIDS Seroconversion
Article | Year |
---|---|
Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents.
Topics: Adolescent; Anti-HIV Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lopinavir; Male; Nitriles; Pyridazines; Pyrimidines; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load | 2012 |
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine | 2012 |
A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir.
Topics: Anti-HIV Agents; Carbamates; Drug Interactions; Drug Therapy, Combination; Furans; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lopinavir; Prospective Studies; Pyrimidinones; Ritonavir; Sulfonamides | 2004 |
16 other study(ies) available for lopinavir and AIDS Seroconversion
Article | Year |
---|---|
Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety.
Topics: Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Female; HIV Seropositivity; Humans; Lamivudine; Lopinavir; Patient Safety; Pregnancy; Ritonavir; Tandem Mass Spectrometry; Viral Load; Zidovudine | 2020 |
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Europe; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Time Factors; United States | 2013 |
Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Lamivudine; Lopinavir; Male; Medication Adherence; Middle Aged; Post-Exposure Prophylaxis; Quebec; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2015 |
[A case of acquired encephalopathy in a child. A cause that we thought had disappeared].
Topics: AIDS Dementia Complex; Anti-HIV Agents; Anti-Infective Agents; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Polymerase Chain Reaction; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2008 |
Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric?
Topics: Administration, Oral; Adult; Benzilates; Cholesterol; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Hydroxycholesterols; Infusions, Intravenous; Lopinavir; Male; Midazolam; Middle Aged; Phenotype; Pyrimidinones; Ritonavir | 2009 |
Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.
Topics: ADP-ribosyl Cyclase 1; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; HIV Seropositivity; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Immunologic Memory; Interleukin-7 Receptor alpha Subunit; Lopinavir; Lymphocyte Activation; Male; Middle Aged; Pilot Projects; Prospective Studies; Ritonavir; T-Lymphocytes; Viral Load | 2012 |
Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.
Topics: Adult; Alkynes; Anti-HIV Agents; Anticoagulants; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Interactions; Female; HIV Seropositivity; Humans; International Normalized Ratio; Lopinavir; Male; Medication Adherence; Patient-Centered Care; Retrospective Studies; Ritonavir; Thromboembolism; Treatment Outcome; United States; Venous Thrombosis; Warfarin | 2012 |
[First evaluations of LPV/RTV (Kaletra) efficacy on HIV-positive patients treated with multiple drugs].
Topics: Adult; Anti-HIV Agents; Female; HIV Seropositivity; Humans; Lopinavir; Male; Pyrimidinones; Retrospective Studies; Time Factors | 2003 |
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
Topics: Adult; Cyclosporine; Drug Interactions; Hepatitis C, Chronic; HIV Protease Inhibitors; HIV Seropositivity; Humans; Liver Transplantation; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir | 2004 |
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Seropositivity; Humans; Longitudinal Studies; Lopinavir; Male; Middle Aged; Oxazines; Pyrimidinones; Retrospective Studies; Ritonavir | 2005 |
Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir.
Topics: Adult; CD4 Lymphocyte Count; Female; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; RNA, Viral; Salvage Therapy; Time Factors; Treatment Outcome | 2005 |
[First-line monotherapy with boostered protease inhibitor. Effectively reduce viral load with only one drug?].
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Early Diagnosis; HIV; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lopinavir; Pyrimidinones; Treatment Outcome; Viral Load | 2005 |
Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.
Topics: Anticonvulsants; Antiretroviral Therapy, Highly Active; Blood Cell Count; Carbamazepine; Drug Interactions; Drug Therapy, Combination; HIV Protease Inhibitors; HIV Seropositivity; Humans; Liver Function Tests; Lopinavir; Male; Middle Aged; Nelfinavir; Pyrimidinones; Ritonavir; Sleep Stages; Viral Load | 2006 |
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Follow-Up Studies; Histocompatibility Testing; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Retrospective Studies; RNA, Viral; Stavudine; Treatment Outcome; Zidovudine | 2006 |
[Thromboembolic events at the time of highly active antiretroviral therapies against human immunodeficiency virus].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Follow-Up Studies; France; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lopinavir; Male; Middle Aged; Pulmonary Embolism; Pyrimidinones; Retrospective Studies; Ritonavir; Venous Thrombosis | 2008 |
[HIV: a guide on management of seropositive patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Clarithromycin; Drug Combinations; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lopinavir; Nutrition Disorders; Patient Care Management; Physician-Patient Relations; Pyrimidinones; Quality of Life; Ritonavir | 2001 |